Zantac Lawsuit Payouts and Settlement Costs Cause Concerns Among Drug Company Investors
Approaching trial dates and analyst estimates that Zantac settlement payouts may reach $45 billion caused investor stock selloff this week
Approaching trial dates and analyst estimates that Zantac settlement payouts may reach $45 billion caused investor stock selloff this week
Motions were filed in advance of hearings scheduled for September 2022, at which time the Court will weigh the reliability of expert testimony on the link between Zantac and cancer.
MDL Judge will decide at a series of Daubert hearings which expert testimony about the link between Zantac and cancer will be admissible at trial
Reports suggest more than 100,000 claims have been registered in the Zantac MDL, alleging various cancers were caused by the recalled heartburn pills
Thousands of lawsuits are being pursued by individuals alleging that recalled Zantac caused cancer. However, MDL expert testimony will only support that the heartburn drug may have caused five specific types of cancer.
The non-adversarial presentations involving the science behind the heartburn drug's cancer risks will be held today and tomorrow in southern Florida.
200 Cases will be selected randomly from more than 100,000 claims presented by former users of the recalled heartburn drug, involving eight different types of cancer allegedly caused by Zantac
The hearing is intended to educate the court on the scientific concepts involved before the first Zantac bellwether trials begin
Early trials for Zantac lawsuits will be chosen from Florida claims, based on the types of cancers diagnosed, to help gauge how juries are likely to respond to evidence and testimony that will be repeated throughout the litigation.